Roswell Park Comprehensive Cancer Center
Roswell Park is the only comprehensive cancer center in Upstate New York designated by the National Cancer Institute. With a history dating back to 1898, it has been a pioneer in cancer research, diagnosis, and treatment, offering innovative therapies and conducting groundbreaking research. The center is committed to reducing the burden of cancer through multidisciplinary care, research, education, and community engagement, aiming to improve patient outcomes and quality of life.
Industries
Nr. of Employees
Very Large (1000+)
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States, North America
Products
GMP engineering and cell manufacturing facility
On-site GMP production facility and processes for manufacturing clinical-grade cell- and gene-based therapeutics to support early-phase trials.
Mobile low-dose CT screening unit
Trailer-mounted low-dose CT capable of performing on-site lung cancer screening exams in community settings.
GMP engineering and cell manufacturing facility
On-site GMP production facility and processes for manufacturing clinical-grade cell- and gene-based therapeutics to support early-phase trials.
Mobile low-dose CT screening unit
Trailer-mounted low-dose CT capable of performing on-site lung cancer screening exams in community settings.
Services
Multidisciplinary cancer clinical care
Specialized clinical services across medical, surgical and radiation oncology, pediatric oncology and supportive/palliative care for diagnosis, treatment and survivorship.
Clinical trials management and investigational product services
Protocol support, trial enrollment, regulatory coordination and investigational agent handling for early- and late-phase oncology trials.
GMP cell and gene therapy manufacturing services
On-site GMP production and process support for manufacturing clinical-grade cell- and gene-based therapeutics for early-phase clinical use.
Shared research core facilities
Centralized access to genomics, bioinformatics, biorepository, flow/immune analysis, bioanalytics/metabolomics and translational imaging to support research programs.
Mobile low-dose CT lung screening
Mobile low-dose CT screening service to provide community-based lung cancer screening and early detection.
Home-based oncology continuity program (PACT)
Home-based visits and teletriage delivering preventive care, symptom management, medication reconciliation and discharge support to reduce hospital readmissions.
Multidisciplinary cancer clinical care
Specialized clinical services across medical, surgical and radiation oncology, pediatric oncology and supportive/palliative care for diagnosis, treatment and survivorship.
Clinical trials management and investigational product services
Protocol support, trial enrollment, regulatory coordination and investigational agent handling for early- and late-phase oncology trials.
GMP cell and gene therapy manufacturing services
On-site GMP production and process support for manufacturing clinical-grade cell- and gene-based therapeutics for early-phase clinical use.
Shared research core facilities
Centralized access to genomics, bioinformatics, biorepository, flow/immune analysis, bioanalytics/metabolomics and translational imaging to support research programs.
Mobile low-dose CT lung screening
Mobile low-dose CT screening service to provide community-based lung cancer screening and early detection.
Home-based oncology continuity program (PACT)
Home-based visits and teletriage delivering preventive care, symptom management, medication reconciliation and discharge support to reduce hospital readmissions.
Expertise Areas
- Clinical trial management
- Immunotherapy and cancer vaccine development
- GMP cell and gene therapy manufacturing
- Genomics and gene-expression profiling
Key Technologies
- Adoptive cellular therapies (e.g., CAR T)
- GMP clinical cell manufacturing
- Multi-parameter flow cytometry
- Gene-expression microarrays and genomic profiling